483 Cumberland Pharmaceuticals Apr 2012

483 Cumberland Pharmaceuticals Apr 2012

Zada Giles FDA, Laura Staples FDA$119.00 - Available Now

FDA investigators audited the Cumberland Pharmaceuticals - Nashville, TN, United States facility and issued 3 inspectional observations (via FDA 483) on 04 Apr 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 04 Apr 2012
  • Location: Nashville, United States
  • FEI: 3003258245
Add To Cart